Details for New Drug Application (NDA): 085353
✉ Email this page to a colleague
NDA 085353 describes THEOCLEAR-200, which is a drug marketed by Cent Pharms and is included in one NDA. Additional details are available on the THEOCLEAR-200 profile page.
The generic ingredient in THEOCLEAR-200 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOCLEAR-200 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 085353
| Tradename: | THEOCLEAR-200 |
| Applicant: | Cent Pharms |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085353
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
